FDA Approved: MESNA — Supplemental Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for MESNA submitted by Sagent Pharmaceuticals, resulting in an approved change to the product’s label/authorization for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Cystitis
• Ifosfamide-induced Hemorrhagic Cystitis

Drugs mentioned

• MESNA (MESNA)

Snippet

SUPPL AP for MESNA (MESNA)